Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 91 from CROI 2018
TUESDAY PLENARY SESSION
THE VAGINAL MICROBIOME AND ACQUISITION OF HIV INFECTION   (ABSTRACT 64)
Nichole Klatt
University of Washington, Seattle, WA, USA
from CROI 2018 on March 6, 2018 8:30 AM-9:30 AM
TUESDAY PLENARY SESSION
ADDRESSING MENTAL HEALTH: A CRUCIAL COMPONENT TO ENDING THE HIV EPIDEMIC   (ABSTRACT 65)
Robert H. Remien
HIV Center for Clinical & Behavioral Studies, NYS Psychiatric Institute and Columbia University, New York, NY, USA
from CROI 2018 on March 6, 2018 8:30 AM-9:30 AM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
HIV TREATMENT, PREVENTION, AND INCIDENCE IN A HYPERENDEMIC UGANDAN FISHING COMMUNITY   (ABSTRACT 90)
Joseph Kagaayi
Rakai Health Science Program, Kalisizo, Uganda
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
PROGRESS TOWARD 90-90-90: 2016 LESOTHO POPULATION-BASED HIV IMPACT ASSESSMENT RESULTS   (ABSTRACT 91)
Kyaw Thin
Ministry of Health Lesotho, Maseru, Lesotho
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
CLINICAL PRESENTATION OF HIV DIFFERS BY AGE IN VACS (2010-2015)   (ABSTRACT 92)
Amy C. Justice
Veterans Administration Connecticut Healthcare System, West Haven, CT, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
THE RAPID ART PROGRAM INITIATIVE FOR HIV DIAGNOSES (RAPID) IN SAN FRANCISCO   (ABSTRACT 93)
Oliver Bacon
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
SAME-DAY ART INITIATION AFTER HOME-BASED HIV TESTING: A RANDOMIZED CONTROLLED TRIAL   (ABSTRACT 94)
Niklaus Daniel Labhardt
Swiss Tropical and Public Health Institute, Basel, Switzerland
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
RANDOMIZED CONTROLLED TRIAL OF FINANCIAL INCENTIVES FOR ACHIEVING VIRAL SUPPRESSION   (ABSTRACT 95)
Harsha Thirumurthy
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
EXTENDED-RELEASE NALTREXONE IMPROVES VIRAL SUPPRESSION IN HIV+ PRISONERS   (ABSTRACT 96)
Sandra Springer
Yale School of Medicine, New Haven, CT, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: 90:90:90: PROGRESS, CHALLENGES, AND NEW TOOLS
HIGHER MORTALITY IN HIV - INFECTED VS - UNINFECTED ADULTS DESPITE ART, BOTSWANA   (ABSTRACT 97)
Tendani Gaolathe
Botswana-Harvard AIDS Institute, Gaborone, Botswana
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
IL-6, D-DIMER OR T-CELLS: WHICH BEST PREDICT EVENTS OR EXPLAIN BENEFITS OF EARLY ART?   (ABSTRACT 74)
Jason V Baker
HCMC / University of Minnesota, Minneapolis, MN, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
SERIOUS CLINICAL OUTCOMES IN HIV-POSITIVE PERSONS WITH CHRONIC KIDNEY DISEASE (CKD)   (ABSTRACT 75)
Lene Ryom
CHIP, Department of Infectious Diseases, Copenhagen, Denmark
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
INCREASED RISK OF PERIPHERAL ARTERY DISEASE IN PERSONS WITH HIV COMPARED TO CONTROLS   (ABSTRACT 76)
Andreas Dehlbæk Knudsen
Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
HIV INFECTION IS ASSOCIATED WITH PROGRESSION OF HIGH RISK CORONARY PLAQUE IN THE MACS   (ABSTRACT 77)
Wendy Post
Johns Hopkins University, Baltimore, MD, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
CAROTID ARTERY ATHEROSCLEROSIS IS ASSOCIATED WITH MORTALITY IN HIV+ WOMEN AND MEN   (ABSTRACT 78)
David B Hanna
Albert Einstein College of Medicine, Bronx, NY, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
IMPACT OF LDMTX ON IMMUNE ACTIVATION AND ENDOTHELIAL FUNCTION IN TREATED HIV   (ABSTRACT 79)
Priscilla Hsue
University of California San Francisco, San Francisco, CA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
PLATELET FUNCTION UPON SWITCHING TO TAF VS CONTINUING ABC: A RANDOMIZED SUBSTUDY   (ABSTRACT 80)
Patrick W.G. Mallon
University College Dublin, Dublin, Ireland
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: NON-AIDS COMPLICATIONS
A TREATMENT AS PREVENTION TRIAL TO ELIMINATE HCV IN HIV+ MSM: THE SWISS HCVREE TRIAL   (ABSTRACT 81LB)
Dominique Laurent Braun
University Hospital Zurich, University of Zurich, Zurich, Switzerland
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
PROTECTION AGAINST REPEATED VAGINAL SHIV CHALLENGES BY BNAB 3BNC117 AND 10-1074   (ABSTRACT 82)
David A Garber
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
LONG-ACTING CABOTEGRAVIR PROTECTS MACAQUES AGAINST REPEATED PENILE SHIV EXPOSURES   (ABSTRACT 83)
Charles Dobard
CDC, atlanta, GA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
GRIFFITHSIN/CARRAGEENAN INSERTS PREVENT SHIV, HSV-2, AND HPV INFECTIONS IN VIVO   (ABSTRACT 84)
Nina Derby
Population Council, New York, NY, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
ORAL FTC/TAF COMBINATION PREVENTS VAGINAL SHIV INFECTION IN PIGTAIL MACAQUES   (ABSTRACT 85)
Ivana Massud
Centres for Disease Control and Prevention, Atlanta , GA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
BY RACE/ETHNICITY, BLACKS HAVE HIGHEST NUMBER NEEDING PREP IN THE UNITED STATES, 2015   (ABSTRACT 86)
Dawn K Smith
Center for Disease Control & Prevention, Atlanta, GA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
GETTING TO ZERO NEW HIV DIAGNOSES IN SAN FRANCISCO: WHAT WILL IT TAKE?   (ABSTRACT 87)
Susan P. Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
RAPID REDUCTION IN HIV DIAGNOSES AFTER TARGETED PREP IMPLEMENTATION IN NSW, AUSTRALIA   (ABSTRACT 88)
Andrew Grulich
University of New South Wales, Sydney, NSW, Australia
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: OF MICE, MONKEYS, AND MEN: PrEP FROM PRECLINICAL TO POPULATION LEVEL IMPACT
LOW DOSE MK-8591 PROTECTS RHESUS MACAQUES AGAINST RECTAL SHIV INFECTION   (ABSTRACT 89LB)
Martin Markowitz
Aaron Diamond AIDS Research Center, New York, NY, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
PERSISTENT DETECTION OF HIV RNA+ CELLS WITH ART STARTED IN FIEBIG 1&2 VS FIEBIG 3-5   (ABSTRACT 66)
Timothy Schacker
University of Minnesota, Minneapolis, MN, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
CD8+ T CELL RESPONSES IN TREATED HYPERACUTE HIV INFECTION LIMIT HIV RESERVOIR SIZE   (ABSTRACT 67)
Zaza Ndhlovu
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
EXPANDED CLONES HARBORING REPLICATION-COMPETENT VIRUS WAX AND WANE OVERTIME   (ABSTRACT 68)
Zheng Wang
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
DETERMINANTS OF HIV-1 RESERVOIR SIZE AND LONG-TERM DYNAMICS UNDER SUPPRESSIVE ART   (ABSTRACT 69LB)
Nadine Bachmann
University Hospital Zurich, Zurich, Switzerland
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
NO EVIDENCE FOR ONGOING HIV REPLICATION IN LYMPH NODES DURING SUPPRESSIVE ART   (ABSTRACT 70)
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
NO RESIDUAL VIRUS REPLICATION IN A RANDOMISED TRIAL OF DOLUTEGRAVIR INTENSIFICATION   (ABSTRACT 71)
Thomas Aagaard Rasmussen
Department of Infectious Diseases, Aarhus University Hospital, Denmark, Aarhus N, Denmark
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
SINGLE ROMIDEPSIN INFUSIONS DO NOT INCREASE HIV EXPRESSION IN PERSONS ON ART (A5315)   (ABSTRACT 72)
Deborah McMahon
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
ORAL ABSTRACT: THE HIV RESERVOIR AND VIRAL REPLICATION
PGT121 COMBINED WITH GS-9620 DELAYS VIRAL REBOUND IN SHIV-INFECTED RHESUS MONKEYS   (ABSTRACT 73LB)
Dan Barouch
Beth Israel Deaconess Medical Center, Boston, MA, USA
from CROI 2018 on March 6, 2018 10:00 AM-12:00 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
THEMED DISCUSSION MODERATOR
Linda Chang
University of Maryland, Baltimore, MD, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
CEREBRAL GLUTATHIONE METABOLISM IN ACUTE HIV INFECTION AND RESPONSE TO ART   (ABSTRACT 437)
Napapon Sailasuta
University of Hawaii, Honolulu, HI, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
AMYLOID UPTAKE BY PET IMAGING SUGGEST PREMATURE AGING IN OLDER HIV+ INDIVIDUALS   (ABSTRACT 438)
Ned W Sacktor
Johns Hopkins University, Baltimore, CA, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
NEUROIMAGING CORRELATES OF FRAILTY, COGNITION, AND HIV   (ABSTRACT 439)
Jeremy Strain
Washington University School of Medicine, St. Louis, MO, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
SUBCLINICAL GLOBAL AND THALAMIC HYPOMETABOLISM ON FDG-PET IN TREATED HIV+ SUBJECTS   (ABSTRACT 440)
Dima A. Hammoud
National Institutes of Health, Bethesda, MD, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
BRAIN VOLUMES CHANGES AFTER ABC/3TC + EFV OR TDF/FTC + ATV/R AS FIRST-LINE ART   (ABSTRACT 425)
Ignacio Pérez-Valero
Hospital La Paz, Madrid, Spain
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: AGING BRAIN AND HIV: BEFORE AND AFTER
QUESTIONS AND ANSWERS
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
THEMED DISCUSSION MODERATOR
Gerardo Garcia-Lerma
Centers for Disease Control and Prevention, Atlanta , GA, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
LOW PREVALENCE OF INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE ACROSS BOTSWANA   (ABSTRACT 542)
Simani Gaseitsiwe
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
HIGH LEVEL RESISTANCE TO DOLUTEGRAVIR (DTG) AFTER EMERGENCE OF T97A MUTATION   (ABSTRACT 543)
Safia S Kuriakose
Leidos Biomedical Research, Inc, Bethesda, MD, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
UNINTEGRATED VIRAL DNA INVOLVED IN DOLUTEGRAVIR RESISTANCE   (ABSTRACT 544)
Olivier Delelis
École Normale Supérieure de Cachan, Cachan, France
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
PREVALENCE AND CLINICAL IMPACT OF MINORITY RESISTANT VARIANTS TO INTEGRASE INHIBITORS   (ABSTRACT 545)
Thuy Thi Thu Nguyen
Hôpital Pitié-Salpêtrière, Laboratoire de Virologie, PARIS, France
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
INTEGRASE INHIBITOR RESISTANCE SELECTIONS INITIATED WITH DRUG RESISTANT HIV-1   (ABSTRACT 546)
Kristen Andreatta
Gilead Sciences, Foster City, CA, USA
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: ARE INTEGRASE STRAND TRANSFER INHIBITORS RESISTANCE PROOF?
QUESTIONS AND ANSWERS
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: BONES OF CONTENTION
THEMED DISCUSSION MODERATOR
Eugènia Negredo
Fundació Lluita Contra la Sida, Badalona, Spain
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
THEMED DISCUSSION: BONES OF CONTENTION
TDF PROPHYLAXIS FOR PMTCT OF HBV: EFFECT ON MATERNAL AND INFANT BONE MINERAL DENSITY   (ABSTRACT 720)
Gonzague Jourdain
Institut de recherche pour le développement, Chiang Mai, Chiang Mai, Thailand
from CROI 2018 on March 6, 2018 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 91 from CROI 2018